RXL holdings
ProShares Ultra Health Care
Positions
70 stored of 70 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co. | US5324571083 | 532457108 | 12.667% | $9.1M | Equity (common) | Corporate | United States | USD |
| 2 | ProShares GENIUS Money Market ETF | US74350P6916 | 74350P691 | 11.806% | $8.5M | Other | Registered fund | United States | USD |
| 3 | Johnson & Johnson | US4781601046 | 478160104 | 7.856% | $5.7M | Equity (common) | Corporate | United States | USD |
| 4 | AbbVie, Inc. | US00287Y1091 | 00287Y109 | 5.568% | $4.0M | Equity (common) | Corporate | United States | USD |
| 5 | UnitedHealth Group, Inc. | US91324P1021 | 91324P102 | 4.984% | $3.6M | Equity (common) | Corporate | United States | USD |
| 6 | Merck & Co., Inc. | US58933Y1055 | 58933Y105 | 4.263% | $3.1M | Equity (common) | Corporate | United States | USD |
| 7 | Total Return Swap | Not reported | Not reported | -4.128% | -$3.0M | Equity derivatives | Other | United States | USD |
| 8 | Total Return Swap | Not reported | Not reported | -3.970% | -$2.9M | Equity derivatives | Other | United States | USD |
| 9 | Repurchase Agreement | Not reported | Not reported | 2.909% | $2.1M | Repurchase agreements | Corporate | United States | USD |
| 10 | Thermo Fisher Scientific, Inc. | US8835561023 | 883556102 | 2.677% | $1.9M | Equity (common) | Corporate | United States | USD |
| 11 | Amgen, Inc. | US0311621009 | 031162100 | 2.624% | $1.9M | Equity (common) | Corporate | United States | USD |
| 12 | Gilead Sciences, Inc. | US3755581036 | 375558103 | 2.413% | $1.7M | Equity (common) | Corporate | United States | USD |
| 13 | Intuitive Surgical, Inc. | US46120E6023 | 46120E602 | 2.182% | $1.6M | Equity (common) | Corporate | United States | USD |
| 14 | Pfizer, Inc. | US7170811035 | 717081103 | 2.153% | $1.6M | Equity (common) | Corporate | United States | USD |
| 15 | Abbott Laboratories | US0028241000 | 002824100 | 2.153% | $1.6M | Equity (common) | Corporate | United States | USD |
| 16 | Repurchase Agreement | Not reported | Not reported | 1.831% | $1.3M | Repurchase agreements | Corporate | United States | USD |
| 17 | Bristol-Myers Squibb Co. | US1101221083 | 110122108 | 1.684% | $1.2M | Equity (common) | Corporate | United States | USD |
| 18 | CVS Health Corp. | US1266501006 | 126650100 | 1.674% | $1.2M | Equity (common) | Corporate | United States | USD |
| 19 | Danaher Corp. | US2358511028 | 235851102 | 1.662% | $1.2M | Equity (common) | Corporate | United States | USD |
| 20 | Vertex Pharmaceuticals, Inc. | US92532F1003 | 92532F100 | 1.645% | $1.2M | Equity (common) | Corporate | United States | USD |
| 21 | Stryker Corp. | US8636671013 | 863667101 | 1.521% | $1.1M | Equity (common) | Corporate | United States | USD |
| 22 | Repurchase Agreement | Not reported | Not reported | 1.373% | $990K | Repurchase agreements | Corporate | United States | USD |
| 23 | Medtronic plc | IE00BTN1Y115 | Not reported | 1.369% | $987K | Equity (common) | Corporate | Ireland | USD |
| 24 | McKesson Corp. | US58155Q1031 | 58155Q103 | 1.315% | $948K | Equity (common) | Corporate | United States | USD |
| 25 | Elevance Health, Inc. | US0367521038 | 036752103 | 1.255% | $905K | Equity (common) | Corporate | United States | USD |
| 26 | Total Return Swap | Not reported | Not reported | -1.240% | -$894K | Equity derivatives | Other | United States | USD |
| 27 | Cigna Group (The) | US1255231003 | 125523100 | 1.057% | $762K | Equity (common) | Corporate | United States | USD |
| 28 | Boston Scientific Corp. | US1011371077 | 101137107 | 1.036% | $747K | Equity (common) | Corporate | United States | USD |
| 29 | Repurchase Agreement | Not reported | Not reported | 1.007% | $726K | Repurchase agreements | Corporate | United States | USD |
| 30 | Regeneron Pharmaceuticals, Inc. | US75886F1075 | 75886F107 | 0.896% | $646K | Equity (common) | Corporate | United States | USD |
| 31 | HCA Healthcare, Inc. | US40412C1018 | 40412C101 | 0.857% | $618K | Equity (common) | Corporate | United States | USD |
| 32 | Cencora, Inc. | US03073E1055 | 03073E105 | 0.758% | $547K | Equity (common) | Corporate | United States | USD |
| 33 | Edwards Lifesciences Corp. | US28176E1082 | 28176E108 | 0.726% | $523K | Equity (common) | Corporate | United States | USD |
| 34 | Cardinal Health, Inc. | US14149Y1082 | 14149Y108 | 0.670% | $483K | Equity (common) | Corporate | United States | USD |
| 35 | IDEXX Laboratories, Inc. | US45168D1046 | 45168D104 | 0.651% | $469K | Equity (common) | Corporate | United States | USD |
| 36 | Becton Dickinson & Co. | US0758871091 | 075887109 | 0.606% | $437K | Equity (common) | Corporate | United States | USD |
| 37 | Agilent Technologies, Inc. | US00846U1016 | 00846U101 | 0.554% | $400K | Equity (common) | Corporate | United States | USD |
| 38 | Waters Corp. | US9418481035 | 941848103 | 0.545% | $393K | Equity (common) | Corporate | United States | USD |
| 39 | Humana, Inc. | US4448591028 | 444859102 | 0.533% | $384K | Equity (common) | Corporate | United States | USD |
| 40 | Zoetis, Inc. Zoetis, Inc., Class A | US98978V1035 | 98978V103 | 0.474% | $342K | Equity (common) | Corporate | United States | USD |
| 41 | Total Return Swap | Not reported | Not reported | -0.455% | -$328K | Equity derivatives | Other | United States | USD |
| 42 | IQVIA Holdings, Inc. | US46266C1053 | 46266C105 | 0.447% | $322K | Equity (common) | Corporate | United States | USD |
| 43 | Biogen, Inc. | US09062X1037 | 09062X103 | 0.416% | $300K | Equity (common) | Corporate | United States | USD |
| 44 | GE HealthCare Technologies, Inc. | US36266G1076 | 36266G107 | 0.411% | $296K | Equity (common) | Corporate | United States | USD |
| 45 | DexCom, Inc. | US2521311074 | 252131107 | 0.411% | $296K | Equity (common) | Corporate | United States | USD |
| 46 | Centene Corp. | US15135B1017 | 15135B101 | 0.403% | $290K | Equity (common) | Corporate | United States | USD |
| 47 | ResMed, Inc. | US7611521078 | 761152107 | 0.402% | $289K | Equity (common) | Corporate | United States | USD |
| 48 | Total Return Swap | Not reported | Not reported | 0.387% | $279K | Equity derivatives | Other | United States | USD |
| 49 | Veeva Systems, Inc. Veeva Systems, Inc., Class A | US9224751084 | 922475108 | 0.381% | $275K | Equity (common) | Corporate | United States | USD |
| 50 | Mettler-Toledo International, Inc. | US5926881054 | 592688105 | 0.347% | $250K | Equity (common) | Corporate | United States | USD |
| 51 | West Pharmaceutical Services, Inc. | US9553061055 | 955306105 | 0.336% | $242K | Equity (common) | Corporate | United States | USD |
| 52 | Total Return Swap | Not reported | Not reported | -0.313% | -$226K | Equity derivatives | Other | United States | USD |
| 53 | Labcorp Holdings, Inc. | US5049221055 | 504922105 | 0.312% | $225K | Equity (common) | Corporate | United States | USD |
| 54 | Quest Diagnostics, Inc. | US74834L1008 | 74834L100 | 0.310% | $224K | Equity (common) | Corporate | United States | USD |
| 55 | STERIS plc | IE00BFY8C754 | Not reported | 0.302% | $218K | Equity (common) | Corporate | Ireland | USD |
| 56 | Viatris, Inc. | US92556V1061 | 92556V106 | 0.271% | $195K | Equity (common) | Corporate | United States | USD |
| 57 | Moderna, Inc. | US60770K1079 | 60770K107 | 0.237% | $171K | Equity (common) | Corporate | United States | USD |
| 58 | Zimmer Biomet Holdings, Inc. | US98956P1021 | 98956P102 | 0.236% | $170K | Equity (common) | Corporate | United States | USD |
| 59 | Incyte Corp. | US45337C1027 | 45337C102 | 0.234% | $169K | Equity (common) | Corporate | United States | USD |
| 60 | Cooper Cos., Inc. (The) | US2166485019 | 216648501 | 0.174% | $125K | Equity (common) | Corporate | United States | USD |
| 61 | Revvity, Inc. | US7140461093 | 714046109 | 0.171% | $124K | Equity (common) | Corporate | United States | USD |
| 62 | Align Technology, Inc. | US0162551016 | 016255101 | 0.169% | $122K | Equity (common) | Corporate | United States | USD |
| 63 | Solventum Corp. | US83444M1018 | 83444M101 | 0.160% | $115K | Equity (common) | Corporate | United States | USD |
| 64 | Insulet Corp. | US45784P1012 | 45784P101 | 0.148% | $106K | Equity (common) | Corporate | United States | USD |
| 65 | Baxter International, Inc. | US0718131099 | 071813109 | 0.140% | $101K | Equity (common) | Corporate | United States | USD |
| 66 | Charles River Laboratories International, Inc. | US1598641074 | 159864107 | 0.129% | $93K | Equity (common) | Corporate | United States | USD |
| 67 | Bio-Techne Corp. | US09073M1045 | 09073M104 | 0.117% | $84K | Equity (common) | Corporate | United States | USD |
| 68 | Universal Health Services, Inc. Universal Health Services, Inc., Class B | US9139031002 | 913903100 | 0.117% | $84K | Equity (common) | Corporate | United States | USD |
| 69 | Henry Schein, Inc. | US8064071025 | 806407102 | 0.111% | $80K | Equity (common) | Corporate | United States | USD |
| 70 | DaVita, Inc. | US23918K1088 | 23918K108 | 0.094% | $68K | Equity (common) | Corporate | United States | USD |